FDA approves vaccine-like RSV shot for infants
Beyfortus should be available this fall and can prevent a disease that kills around 300 children per year
Source: yahoo.com
Page 36 - John Farley News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Farley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Farley Today - Breaking & Trending Today
FDA Approval of RSV Drug Gives Infants and Toddlers Long-Lasting Protection
AstraZeneca and Sanofi drug Beyfortus is now FDA approved for preventing respiratory problems from RSV infection in infants and toddlers. Antibody engineering enables the drug to last longer in the body, providing protective effects for potentially the entire RSV season.
Source: medcitynews.com
RSV antibody shot nirsevimab gets FDA approval to protect infants from virus
Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.
Source: abc7.com
FDA approves new drug Beyfortus to protect babies, toddlers from RSV
The Food and Drug Administration announced Monday that it has approved the new drug Beyfortus in an effort to fight the spread of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in newborns and toddlers. The approval to AstraZeneca - which is involved in producing the drug - comes about two months after the FDA
Source: wfin.com
New drug to protect babies, toddlers from RSV gets FDA approval
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of...
Source: thegrio.com